ESMO 2023: Updates in Non-Small Cell Lung Cancer (NSCLC)

home / post-conference-perspectives / esmo-2023-updates-in-non-small-cell-lung-cancer-nsclc

Patrick Forde, MBBCh, offers crucial perspectives on breakthroughs in Non-Small Cell Lung Cancer from ESMO 2023.

Video 1 - "CheckMate 77T: Perioperative Immunotherapy in Resectable NSCLC"

EP. 1: CheckMate 77T: Perioperative Immunotherapy in Resectable NSCLC

November 10th 2023

Patrick Forde, MBBCh, shares insights on perioperative immunotherapy in the CheckMate-77T study presented at ESMO 2023.

Watch

EP. 2: Evolving NSCLC Landscape: Comparing Recent Updates in Neoadjuvant and Perioperative Immunotherapy

November 10th 2023

An expert comparison of recent data on neoadjuvant and perioperative immunotherapy in resectable early-stage NSCLC, including CheckMate 77T, CheckMate-816, and KEYNOTE-671.

Watch

Video 3 - "Updates in ALK+ NSCLC: ALINA Trial at ESMO 2023"

EP. 3: Updates in ALK+ NSCLC: ALINA Trial at ESMO 2023

November 10th 2023

Patrick Forde, MBBCh, discusses ALK rearrangement in NSCLC and highlights ALINA trial results from ESMO 2023.

Watch

Video 4 - "Lessons From LIBRETTO-431 Trial in RET+ NSCLC"

EP. 4: Lessons from LIBRETTO-431 Trial in RET+ NSCLC

November 17th 2023

An overview of data presented at ESMO 2023 on the LIBRETTO-431 trial of selpercatinib in RET+ NSCLC.

Watch

Video 5 - "PAPILLON Trial Insights: ESMO 2023"

EP. 5: PAPILLON Trial Insights: ESMO 2023

November 17th 2023

Patrick Forde, MBBCh, discusses advances in EGFR Exon 20 insertion-mutated NSCLC.

Watch

Video 6 - "Innovations Needed and Future Directions in Treatment of NSCLC"

EP. 6: Innovations Needed and Future Directions in Treatment of NSCLC

November 17th 2023

Concluding thoughts on data presented at ESMO 2023, and innovations still needed for improved survival of NSCLC—provided by Patrick Forde, MBBCh.

Watch

Do Not Sell My Information

Terms & Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777